These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 21772306
1. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus. Sun C, Falagas ME, Wang R, Karageorgopoulos DE, Yu X, Liu Y, Cai Y, Liang B, Song X, Liu Z. J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306 [Abstract] [Full Text] [Related]
2. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus. Yu XH, Song XJ, Cai Y, Liang BB, Lin DF, Wang R. J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368 [Abstract] [Full Text] [Related]
8. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Sahuquillo Arce JM, Colombo Gainza E, Gil Brusola A, Ortiz Estévez R, Cantón E, Gobernado M. Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793 [Abstract] [Full Text] [Related]
10. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method. Quentin C, Saivin S, Lafferriere C, Noury P, Bebear C. Drugs Exp Clin Res; 1987 Sep; 13(4):219-24. PubMed ID: 3476291 [Abstract] [Full Text] [Related]
12. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009. Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T. Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146 [Abstract] [Full Text] [Related]
14. [Investigation of the Antibacterial Synergistic Activity of Fosfomycin-Teicoplanin Combination in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Various Clinical Sample]. Biçer RT, Özekinci T, Koçoğlu ME. Mikrobiyol Bul; 2024 Apr; 58(2):113-124. PubMed ID: 38676580 [Abstract] [Full Text] [Related]
15. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii. Bishburg E, Bishburg K. Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876 [Abstract] [Full Text] [Related]
16. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms. Tang HJ, Chen CC, Cheng KC, Toh HS, Su BA, Chiang SR, Ko WC, Chuang YC. J Antimicrob Chemother; 2012 Apr; 67(4):944-50. PubMed ID: 22258931 [Abstract] [Full Text] [Related]
17. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus. Huang V, Cheung CM, Kaatz GW, Rybak MJ. Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792 [Abstract] [Full Text] [Related]
18. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field. Matsumoto T, Kubo S, Haraoka M, Takahashi K, Tanaka M, Sakumoto M, Kumazawa J. Clin Ther; 1993 Jan; 15(5):819-28. PubMed ID: 8269448 [Abstract] [Full Text] [Related]
19. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus. McConeghy KW, LaPlante KL. Diagn Microbiol Infect Dis; 2010 Sep; 68(1):1-6. PubMed ID: 20727462 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea. Nam HM, Lee AL, Jung SC, Kim MN, Jang GC, Wee SH, Lim SK. Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263 [Abstract] [Full Text] [Related] Page: [Next] [New Search]